Logo

American Heart Association

  65
  0


Final ID: Wed095

Reduced Hypusination of eIF5A Suppresses Generation of Free Ubiquitin and Protein Ubiquitination Resulting in Heart Failure with Preserved Ejection Fraction

Abstract Body: Heart failure with preserved ejection fraction (HFpEF) accounts for more than half of all HF, yet effective therapies remain limited. Metabolomics of myocardial biopsies from patients with HFpEF revealed spermidine the most upregulated. Spermidine is critical to ribosomal translation due to its engagement with hypusination of the post-translation modification of eukaryotic translation initiation factor 5A (eIF5AHyp). We find eIF5AHyp to be decreased in HFpEF but not HFrEF, associated with reduced expression of the primary synthetic enzyme deoxy hypusine synthase (DHPS). Accordingly, mice with cardiomyocyte specific conditional knockout of DHPS (cDHPS-KO) were generated and display preserved ejection fraction yet increased E/E’, pulmonary edema, and exercise intolerance. Ribosome profiling and sequencing was performed to assess transcripts with impaired translation, and among those identified, gene ontology highlighted ubiquitin related pathways. CRISPR knock-out of DHPS in neonatal rat cardiomyocytes reduces eIF5AHyp, total ubiquitinated proteins, and free ubiquitin. Reducing eIF5AHyp pharmacologically and genetically leads to accumulation of protein aggregates in cardiomyocytes but they are less ubiquitinated. The ubiquitin precursor, UBC encoding 9 ubiquitin monomers, and deubiquitinases, USP7, USP16, and USP9X, are required to generate free ubiquitin, and all have reduced expression in myocytes with reduced eIF5AHyp, in cDHPS-KO hearts, and human HFpEF myocardium. Transfection of recombinant single ubiquitin suppresses toxicity seen in cardiomyocytes with reduced eIF5AHyp. In conclusion, we have identified impaired protein quality control that is unique to HFpEF, caused by reduced eIF5AHyp that in turn impairs translation of UBC and key deubiquitinases required to generate free ubiquitin.
  • Koleini, Navid  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Zhao, Liang  ( Complete Omics , Baltimore , Maryland , United States )
  • Chaerkady, Raghothama  ( Complete Omics , Baltimore , Maryland , United States )
  • Hahn, Virginia  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Sharma, Kavita  ( Johns Hopkins University SOM , Baltimore , Maryland , United States )
  • Ranek, Mark  ( JOHNS HOPKINS MEDICAL INSTITUTIONS , Baltimore , Maryland , United States )
  • Pearce, Erika  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Green, Rachel  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Kass, David  ( JOHNS HOPKINS MEDICAL INST , Baltimore , Maryland , United States )
  • Meddeb, Mariam  ( The Johns Hopkins University , Baltimore , Maryland , United States )
  • Keykhaei, Mohammad  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Saba, James  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Farshidfar, Farnaz  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Kwon, Seoyoung  ( Johns Hopkins , Baltimore , Maryland , United States )
  • Calahatian, Angela  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Mandarano, Lorena  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Lei, Shunyao  ( Johns Hopkins University , Baltimore , Maryland , United States )
  • Author Disclosures:
    Navid Koleini: DO NOT have relevant financial relationships | Liang Zhao: DO NOT have relevant financial relationships | Raghothama Chaerkady: No Answer | Virginia Hahn: DO NOT have relevant financial relationships | Kavita Sharma: No Answer | Mark Ranek: No Answer | Erika Pearce: No Answer | Rachel Green: No Answer | David Kass: DO have relevant financial relationships ; Advisor:Amgen:Active (exists now) ; Consultant:Lilly:Active (exists now) ; Consultant:Gordian:Active (exists now) ; Consultant:Alleviant:Active (exists now) ; Advisor:Bayer:Active (exists now) ; Advisor:Cytokinetics:Active (exists now) ; Advisor:Cardurion:Active (exists now) | Mariam Meddeb: No Answer | Mohammad Keykhaei: No Answer | James Saba: No Answer | Farnaz Farshidfar: No Answer | Seoyoung Kwon: No Answer | Angela Calahatian: No Answer | Lorena Mandarano: No Answer | Shunyao Lei: DO NOT have relevant financial relationships
Meeting Info:

Basic Cardiovascular Sciences 2025

2025

Baltimore, Maryland

Session Info:

Poster Session and Reception 1

Wednesday, 07/23/2025 , 04:30PM - 07:00PM

Poster Session and Reception

More abstracts on this topic:
3-Mercaptopyruvate Sulfurtransferase is a Critical Regulator of Branched-Chain Amino Acid Catabolism in Cardiometabolic HFpEF

Li Zhen, Doiron Jake, Xia Huijing, Lapenna Kyle, Sharp Thomas, Yu Xiaoman, Nagahara Noriyuki, Goodchild Traci, Lefer David

Phosphorylation of CHIP Protects Ovariectomized Female Mice From Myocardial Infarction

Stevens Lara, Mckoy Desirae, Parveen Admira, Garg Parisha, Koilada Sangeeta, Ranek Mark

More abstracts from these authors:
ATP Citrate Lyase Supports Cardiac Function and NAD+/NADH Balance And Is Depressed in Human Heart Failure

Meddeb Mariam, Paolocci Nazareno, Hahn Virginia, Sharma Kavita, Pearce Erika, Kass David, Koleini Navid, Jun Seungho, Keykhaei Mohammad, Farshidfar Farnaz, Zhao Liang, Kwon Seoyoung, Lin Brian, Keceli Gizem

Integrated Multi-Omics Analysis Reveals Suppressed Mitochondrial Fuel Metabolism in HFpEF Myocardium

Keykhaei Mohammad, Kass David, Hahn Virginia, Jenkin Sydney, Koleini Navid, Tajdini Masih, Rezaee Malihe, Mulligan Abigail, Calahatian Angela, Jani Vivek, Sharma Kavita

You have to be authorized to contact abstract author. Please, Login
Not Available